Hello fellow traders. We are experiencing a respectable pullback on many names these past few days. CRISPR is one of them. This stock has actually been in correction for sometime now, which picked up pace after disappointing earnings last week. We may see more downside in the short term if the market continues the selloff but this company is definitely a buy in my...
In my previous post on #CRISPR I talked about the Green upward sloping trendline & how every time CRSPR has traded on or below it since May 2017 we've seen parabolic action.
I don't want to say I told you so, but we've seen some parabolic action.
To my surprise, the parabolic movement came the news of Vertex upfront payment of $175 million upfront payment....
